Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2025-12-24 @ 11:52 AM
Study NCT ID:
NCT01894061
Status:
COMPLETED
Last Update Posted:
2025-02-17
First Post:
2013-07-03
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-03
First Submit QC Date:
None
Study First Post Date:
2013-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-10-09
Results First Submit QC Date:
None
Results First Post Date:
2025-02-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-13
Last Update Post Date:
2025-02-17
Last Update Post Date Type:
ACTUAL